Calidi Biotherapeutics Inc (CLDI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,209 | -18,061 | -12,992 | -7,225 | -29,216 |
| Depreciation Amortization | 1,580 | 1,183 | 784 | 390 | 1,688 |
| Accounts payable and accrued liabilities | -628 | 537 | 1,142 | 968 | -6,170 |
| Other Working Capital | -1,698 | 552 | 1,140 | 1,917 | -6,242 |
| Other Operating Activity | 3,261 | 1,518 | 601 | 119 | 12,957 |
| Operating Cash Flow | $-19,694 | $-14,271 | $-9,325 | $-3,831 | $-26,983 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16 | -11 | -5 | -5 | -585 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 107 |
| Investing Cash Flow | $-16 | $-11 | $-5 | $-5 | $-478 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 1,250 |
| Debt Issued | 3,800 | 3,800 | 3,000 | 3,000 | 2,000 |
| Debt Repayment | -1,582 | -1,863 | -1,545 | -23 | -101 |
| Common Stock Issued | 25,010 | 11,383 | 7,648 | N/A | 281 |
| Other Financing Activity | 137 | 939 | -890 | 36 | 25,614 |
| Financing Cash Flow | $27,365 | $14,259 | $8,213 | $3,013 | $29,044 |
| Exchange Rate Effect | -13 | -29 | 4 | 17 | -6 |
| Beginning Cash Position | 2,167 | 2,167 | 2,167 | 2,167 | 590 |
| End Cash Position | 9,809 | 2,115 | 1,054 | 1,361 | 2,167 |
| Net Cash Flow | $7,642 | $-52 | $-1,113 | $-806 | $1,577 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,694 | -14,271 | -9,325 | -3,831 | -26,983 |
| Capital Expenditure | -16 | -11 | -5 | -5 | -585 |
| Free Cash Flow | -19,710 | -14,282 | -9,330 | -3,836 | -27,568 |